Skip to main content
$2.26 -$0.17 (-699.6%)

12:00 PM EDT on 10/21/20

ZIOPHARM Oncology (NASDAQ:ZIOP)

CAPS Rating: 1 out of 5

Current Price $2.26 Mkt Cap $517.1M
Open $2.42 P/E Ratio 0.00
Prev. Close $2.43 Div. (Yield) $0.00 (0.0%)
Daily Range $2.25 - $2.44 Volume 1,776,322
52-Wk Range $1.80 - $5.61 Avg. Daily Vol. 1,443,762

Caps

How do you think NASDAQ:ZIOP will perform against the market?

Add Stock to CAPS Watchlist

All Players

102 Outperform
18 Underperform
 

All-Star Players

13 Outperform
9 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ZIOP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

mavrant (< 20)
Submitted June 02, 2011

possible new technology

zzlangerhans (98.43)
Submitted November 14, 2014

Ziopharm is up a decent chunk today, icing on the cake for anyone who found the stub tasty at October lows under 2.5. Nevertheless, I don't see this upswing carrying on past the company's presentations at AACR at the beginning of December. It seems… More

NASDAQ:ZIOP VS S&P 500 (SPY)

Fools bullish on NASDAQ:ZIOP are also bullish on:

Fools bearish on NASDAQ:ZIOP are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about ZIOP.

Recs

0
Member Avatar FVelociraptor (99.54) Submitted: 10/21/2020 3:20:43 PM : Underperform Start Price: $2.37 NASDAQ:ZIOP Score: -0.51

https://velociraptor.cc

Recs

0
Member Avatar TerryHogan (99.95) Submitted: 11/27/2018 12:50:05 AM : Underperform Start Price: $3.49 NASDAQ:ZIOP Score: +60.92

Cash is running through this thing like corn in the dysentery ward. They are funding themselves solely on share dilution which has been steady for the past 4 years. There was a sharp ratcheting down of R&D expenditure in 2017, but no revenue, which to me is not a good sign. Like all pre-production biopharmas this thing is a lottery ticket and you get paid if they discover something big and marketable, but your expected return is zero.

Recs

0
Member Avatar sk2129 (31.02) Submitted: 1/14/2016 2:06:37 PM : Outperform Start Price: $6.16 NASDAQ:ZIOP Score: -140.08

baker bros.

Leaderboard

Find the members with the highest scoring picks in ZIOP.

Score Leader

EdFromOhio

EdFromOhio (42.62) Score: +424.12

The Score Leader is the player with the highest score across all their picks in ZIOP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
AGCAPS1 < 20 1/26/2011 Underperform 1Y $5.98 -60.45% +164.02% +224.48 1 Comment
bluebare 33.77 11/14/2012 Underperform 5Y $4.47 -47.09% +147.98% +195.07 0 Comment
dpgardne < 20 10/10/2012 Underperform 5Y $5.02 -52.89% +137.71% +190.60 0 Comment
GreenAB 29.80 3/5/2015 Underperform 5Y $13.94 -83.03% +62.67% +145.70 0 Comment
sjinvestor 63.99 1/16/2015 Underperform 3Y $8.11 -70.84% +72.43% +143.26 0 Comment
Hendrickson71 < 20 12/7/2015 Underperform 3W $10.32 -77.08% +65.12% +142.21 1 Comment
KidJones 48.89 1/13/2015 Underperform 5Y $5.99 -60.52% +67.91% +128.42 0 Comment
AmigableRafa 93.64 6/30/2014 Underperform 5Y $4.06 -41.75% +74.94% +116.69 0 Comment
SimonSaysSell 98.06 11/17/2014 Underperform NS $3.87 -38.89% +68.13% +107.02 0 Comment
zzlangerhans 98.43 11/14/2014 Underperform 1Y $3.70 -36.08% +68.02% +104.10 3 Comments

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ZIOP.